Abstract
CELLULAR resistance to drugs or chemicals, which can be “natural”1–4 or “acquired”5,6, is important particularly in the treatment of infectious diseases by antibiotics and of tumour cells by cancer chemotherapeutic drugs. I have investigated the mechanism of cellular drug resistance using mammalian cell lines resistant to actinomycin D. In murine leukaemias7, HeLa cells8 and bacteria9 this resistance has been related to membrane permeability barriers which prevent the interaction of actinomycin D with deoxyguanosine residues in DNA, stopping its pharmacological action. Earlier I had found that L5178Y (mouse lymphoma cell line) and L5178Y/D (actinomycin D-resistant subline) glycosidase10 and glycoprotein: glycosyl transferase11 activities, which are important in membrane glycoprotein catabolism and anabolism, were altered in the resistant lines. I have now shown that surface membranes are affected, particularly the glycoproteins and glycolipids and their synthesis in the cells resistant to actinomycin D. In this article I shall develop the hypothesis that acquired drug resistance occurs through selection of cells with altered membranes and altered membrane synthetic apparatus, and that such membrane changes decrease drug permeability and thus increase drug resistance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hurwitz, J., Furth, J. J., Malamy, M., and Alexander, M., Proc. US Nat. Acad. Sci., 48, 1222 (1962).
Haywood, A. M., and Sinsheimer, R. L., J. Mol. Biol., 6, 247 (1963).
Mach, D., and Tatum, E. L., Science, 139, 1051 (1963).
Leive, L., Biochem. Biophys. Res. Commun., 18, 13 (1965).
Schwartz, H. S., Sodergren, J. E., and Ambaye, R. Y., Cancer Res., 28, 192 (1968).
Kessel, D., Botterill, V., and Wodinsky, I., Cancer Res., 28, 938 (1968).
Kessel, D., and Wodinsky, I., Biochem. Pharmacol., 17, 161 (1968).
Goldstein, M. N., Hamm, K., and Amrod, E., Science, 151, 1555 (1966).
Slotnick, I. J., and Sells, B. H., Science, 146, 407 (1964).
Bosmann, H. B., and Kessel, D., Mol. Pharmacol., 6, 345 (1970).
Kessel, D., and Bosmann, H. B., Cancer Res., 30, 2695 (1970).
Biedler, J. L., and Riehm, H., Cancer Res., 30, 1174 (1970).
Bosmann, H. B., J. Biol. Chem., 246, 3817 (1971).
Barland, P., and Schroeder, E. A., J. Cell Biol., 46, 622 (1970).
Dische, Z., Meth. Carbohydrate Chem., 1, 478 (1962).
Dische, Z., Ann. NY Acad. Sci., 106, 259 (1963).
Svennerholm, L., Acta Chem. Scand., 12, 547 (1958).
Cook, G. M. W., and Jacobson, W., Biochem. J., 107, 549 (1968).
Laico, M. T., Ruoslahti, E. I., Papermaster, D. S., and Dwyer, W. J., Proc. US Nat. Acad. Sci., 67, 120 (1970).
Bosmann, H. B., Case, K. R., and Shea, M. B., FEBS Lett., 11, 261 (1970).
Walborg, E. F., Lantz, R. S., and Wray, V. P., Cancer Res., 29, 2039 (1969).
Bosmann, H. B., Hagopian, A., and Eylar, E. H., Arch. Biochem. Biophys., 128, 51 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BOSMANN, H. Mechanism of Cellular Drug Resistance. Nature 233, 566–569 (1971). https://doi.org/10.1038/233566a0
Received:
Revised:
Issue date:
DOI: https://doi.org/10.1038/233566a0
This article is cited by
-
5-Fluorouracil containing combinations in murine tumor systems
Investigational New Drugs (1989)
-
Lectin staining patterns of plasma membranes of daunorubicin and vincristine resistant Ehrlich ascites tumour cells
Virchows Archiv B Cell Pathology Including Molecular Pathology (1987)